Search Results
346 Results for 'Therapeutics & Vaccines'
PAGE 1 OF 14
Technology
Synthesis Of Indole Thiazole Compounds As Ligands For The Ah Receptor
Pawel Grzywacz, Hector DeLuca, Rafal Sicinski | P02237US
Technology
Methods And Compositions For Phosphate Binding
Hector DeLuca, Katarzyna Barycka, Lori Plum, Julia Zella, Margaret Clagett-Dame | P08110US
Technology
Synthesis Of A-ring Synthon Of 19-nor-1alpha,25-dihydroxyvitamin D3 From (d)-glucose
Hector DeLuca, Masato Shimizu, Sachiko Yamada | P04088US
Technology
Use Of Neuropeptides For Ligament, Cartilage, And Bone Healing
Ray Vanderby, Kelley Grorud | P05193US
Technology
Use Of Aryl Hydrocarbon Receptor Ligand As A Therapeutic Intervention In Angiogenesis-implicated Dis
Jiasheng Song, Hector DeLuca, Margaret Clagett-Dame, Stuart Helfand, Nasim Akhtar | P06145US
Technology
2-methylene-19-nor-20(s)-1 Alpha-hydroxy-bis-homo-pregnacalciferol In Crystalline Form
Hector DeLuca, James Thoden, Hazel Holden, Margaret Clagett-Dame, Pawel Grzywacz, Sumithra Gowlugari | P02175US
Technology
Combination Of Low Dose 2-Methylene-19-Nor-(20s)-1alpha,25-Dihydroxyvitamin D3 And Calcimimetics To Treat Secondary Hyperparathyroidism
Hector DeLuca, Margaret Clagett-Dame, Lori Plum | P170053US03
Technology
Synthesis Of A-ring Synthon Of 19-nor-1alpha,25-dihydroxyvitamin D3 From (d)-glucose
Hector DeLuca, Masato Shimizu, Sachiko Yamada | P01038US
Technology
2-methylene-19-nor Vitamin D2 Compounds
Hector DeLuca, Sumithra Gowlugari, Rafal Sicinski | P02026US
Technology
Influenza M2 Protein Mutant Viruses As Influenza Live Attenuated Vaccines
Yoshihiro Kawaoka, Tokiko Watanabe | P07509US
Technology
Once-A-Week Administration Of 25-Hydroxy Vitamin D3 To Sustain Elevated Steady-State Pharmacokinetic Blood Concentration
Hector DeLuca, Lori Plum, Margaret Clagett-Dame | P08138US02
Technology
High-Potency Botulinum Toxin Formulations
Gary Borodic | P08444US01
Technology
Methods For Detecting Risk Of Fatal Prostate Cancer Using Serum Calcium
Halcyon Skinner, Gary Schwartz | P09131US01
Technology
Drugs To Prevent Hpv Infection
Paul Lambert, Paul Ahlquist, Dohun Pyeon, Hao-Shun Huang | P08406US02
Technology
2-methylene-20(21)-dehydro-19-nor-vitamin D Analogs
Hector DeLuca, Bulli Padmaja Tadi, Lori Plum, Margaret Clagett-Dame | P08364US
Technology
2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin D Analogs
Hector DeLuca, Bulli Padmaja Tadi, Lori Plum, Margaret Clagett-Dame | P08365US
Technology
2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-1,24(r)-dihydroxy-19-nor-vitamin D3
Hector DeLuca, Rafal Barycki, Lori Plum, Margaret Clagett-Dame | P08397US
Technology
19-nor-vitamin D Analogs With 1,2-dihydrofuran Ring
Hector DeLuca, Katarzyna Sokolowska, Rafal Sicinski, Lori Plum, Margaret Clagett-Dame, Agnieszka Glebocka | P08399US
Technology
19-nor-vitamin D Analogs With 3,2-dihydrofuran Ring
Hector DeLuca, Katarzyna Sokolowska, Rafal Sicinski, Lori Plum, Margaret Clagett-Dame, Agnieszka Glebocka | P08400US
Technology
2-methylene-(20s,25s)-19,26-dinor-vitamin D Analogs
Hector DeLuca, Lori Plum, Margaret Clagett-Dame, Grazia Chiellini, Pawel Grzywacz | P08089US
Technology
2-methylene-(20s,25r)-19,26-dinor-vitamin D Analogs
Hector DeLuca, Lori Plum, Margaret Clagett-Dame, Grazia Chiellini, Pawel Grzywacz | P08090US
Technology
2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D Analogs
Hector DeLuca, Lori Plum, Agnieszka Glebocka, Margaret Clagett-Dame, Rafal Sicinski | P08106US
Technology
(20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D Analogs
Hector DeLuca, Rafal Barycki, Lori Plum, Margaret Clagett-Dame | P07332US
Technology
(20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D Analogs
Hector DeLuca, Rafal Barycki, Lori Plum, Margaret Clagett-Dame | P07333US
Technology
Reversible Natural Product Glycosyltransferase-catalyzed Reactions, Compounds And Related Methods
Jon Thorson, Byron Griffith, Changsheng Zhang | P06427US